Skip to content
Home
Science
Our Approach
Oncology
Arthritis
Inflammatory Bowel Disease
Pipeline
Company
About Us
Our Name
Our Team
News
In the News
Press Releases
Publications
Menu
Home
Science
Our Approach
Oncology
Arthritis
Inflammatory Bowel Disease
Pipeline
Company
About Us
Our Name
Our Team
News
In the News
Press Releases
Publications
Protecting the Extracellular Matrix
Albatroz Therapeutics is developing first-in-class antibodies against a novel target critical to the integrity of the extracellular matrix, addressing some of the toughest challenges in human health, beginning with cancer and arthritis.
Learn About Our Science